By: Björn

Workshop at ERA-NET Neuron meeting
January 30, 2019

ERA-NET Neuron organised a workshop research data quality on January 22nd, 2019 in Bonn. PAASP Team members, Anton Bespalov and Martin…

Read More
Max Planck Society ends Elsevier subscription
January 2, 2019

The Max Planck Society (MPS) is a German research organisation acting in many different research areas and consists of over 14.000…

Read More
The hidden message
December 20, 2018

Read More
Guidelines rule! And not only in the area of preclinical biomedical research
December 20, 2018

Thanks to this ‘Christmas Tree Decoration Guide’ we can finally decorate a Christmas tree properly and in a reproducible manner…

Read More
Collection of resources for the use of R in study design and analysis
December 20, 2018

In the recent report on „Digital tools and services to support research replicability and verifiability”, Caroline Skirrow and Markus Munafó have argued that…

Read More
The SOD1 mouse – 10 years later
December 20, 2018

It has been more than 10 years since two seminal papers by Ludolph et al (2007) and Scott et al (2008) have introduced recommendations for…

Read More
Balancing futility and benefit – Is academic research ready for higher research quality standards?
December 20, 2018

byAnton Bespalov (PAASP)Adrian G. Barnett (Queensland University of Technology, Brisbane, Australia)C. Glenn Begley (BioCurate, Melbourne, Australia) *For a condensed version of this…

Read More
Additional Reads in December 2018
December 20, 2018

Statistical pitfalls of personalized medicine How sure are you of your result? Put a number on it Design preclinical studies for…

Read More
To Read More Papers, or to Read Papers Better? A Crucial Point for the Reproducibility Crisis 
December 20, 2018

To Read More Papers, or to Read Papers Better? A Crucial Point for the Reproducibility Crisis  A huge number of new…

Read More
How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation
December 20, 2018

Reproducibility in preclinical research may be low because of the high prevalence of biases and of suboptimal research practices (such as…

Read More